Practical Phramacolgy

PHARMACOLOGY OF THE EYE

Physiological Anatomy of the Eye

Sympathetic Nervous System

mydriasis- contract pupillary dilator muscle (1 receptor)Relax ciliary muscle for distant vision (Я2 receptors)Enhance aqueous humor formation (Я2 receptors)Inhibit aqueous humor formation (2 receptors)

Parasympathetic Nervous System Actions

focus eye for near vision (ciliary muscle contraction) constrict pupil (miosis)-(pupillary sphincter contraction) Enhance drainage of aqueous humor All of these effects mediated by muscarinic receptors

Drugs promoting mydriasis (pupil dilation)

Sympathomimetics (stimulate or mimic stimulation of sympathetic nerves) Inhibitors of parasympathetic nervous system (Atropine)

Pupillary Muscles

Mydriasis

Miosis

Mydriatics

Agents releasing norepinephrine NICOTINE activates nicotinic receptor (also activates parasympathetics to produce miosis, which is the more common reaction) . Cocaine increase norepinephrine concentrations of adrenergic receptors Amphetamine hydroxyamphetamine (0.1% solution) used to diagnose post-ganglionic nerve damage vs. a defect prior to the postganglionic nerve (no reaction means postganglionic nerve defect). response to amphetamine indicates normal post-ganglionic nerve

Alpha1 adrenergic stimulants

PHENYLEPHRINE (mydrifrin) is a drug used in eye drops to dilate pupil 2.5% to 10% solution used to produce mydriasis Epinephrine (Epitrate) 0.5 to 2% solution to treat glaucoma increases aqueous humor outflow

Muscarinic receptor antagonists

ATROPINE (Atriposol)- (0.5 to 3% solution) to produce cycloplegia (is paralysis of the ciliary muscle of the eye, resulting in a loss of accommodation.)

Drugs producing miosis

Nicotine activates parasympathetic nerves Muscarinic agonists such as Pilocarpine (Pilocar) used as 2% solution acetylcholine (Miochol)

Agents preventing acetylcholine degradation

Physostigmine , Ecothiophate (phospholine iodide), Alpha1 receptor antagonists Norepinephrine depleting agents- Reserpine (Serpasil)- have the potential of causing ocular side effects (miosis; ptosis)


Drugs for Treatment of Glaucoma

Drugs used to treat ptosis

disruption of sympathetic innervation of superior tarsalis muscle of the eyelid (Horner’s Syndrome)- can reverse with Phenylephrine

Routes of Administration

eye drops, ointments, injections

Eye drops

Factors affecting absorption:1- drug concentration and solubility (aqueous solution v’s suspension)2- viscosity (increased residence time)3- lipid solubility: lipid rich epithelial cell membrane v’s water rich site 4- pH and ionic charge - most eye drops are weak bases existing in both charged and uncharged forms enhancing absorption

Eye ointments

increases contact time of drug with ocular surface mixture of petrolatum and mineral oil water-soluble drugs are insolvent in the ointment and are present as microcrystals. The surface microcrystals dissolve in the tears, the rest are trapped until the ointment melts

Eye ointments

Only drugs with high lipid solubility and some water solubility will get into both tears and corneal epithelium Ex . chloramphenicol and tetracycline both achieve higher aqueous levels as ointment rather than drops

Peri-ocular injections

subconjunctival, allow drugs to bypass the conjunctival/corneal epithelial barrier and reach therapeutic levels in the posterior segment eg anaesthetic agents, steroids,


Intraocular injections

Intravitreal injection

Systemic
drug getting into eye from systemic circulation limited drugs with higher lipid solubility pass through blood-ocular barrier more readily

Systemic

extent of drug bound to plasma proteins also effects access of drug into eye - only unbound form can pass blood-ocular barrier